Cite
Yang MG, Xiao Z, Cherney RJ, et al. Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672. ACS Med Chem Lett. 2019;10(3):300-305doi: 10.1021/acsmedchemlett.8b00439.
Yang, M. G., Xiao, Z., Cherney, R. J., Tebben, A. J., Batt, D. G., Brown, G. D., Chen, J., Cvijic, M. E., Dabros, M., Duncia, J. V., Galella, M., Gardner, D. S., Khandelwal, P., Ko, S. S., Malley, M. F., Mo, R., Pang, J., Rose, A. V., Santella, J. B., Shi, H., Srivastava, A., Traeger, S. C., Wang, B., Xu, S., Zhao, R., Barrish, J. C., Mandlekar, S., Zhao, Q., & Carter, P. H. (2019). Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672. ACS medicinal chemistry letters, 10(3), 300-305. https://doi.org/10.1021/acsmedchemlett.8b00439
Yang, Michael G, et al. "Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672." ACS medicinal chemistry letters vol. 10,3 (2019): 300-305. doi: https://doi.org/10.1021/acsmedchemlett.8b00439
Yang MG, Xiao Z, Cherney RJ, Tebben AJ, Batt DG, Brown GD, Chen J, Cvijic ME, Dabros M, Duncia JV, Galella M, Gardner DS, Khandelwal P, Ko SS, Malley MF, Mo R, Pang J, Rose AV, Santella JB, Shi H, Srivastava A, Traeger SC, Wang B, Xu S, Zhao R, Barrish JC, Mandlekar S, Zhao Q, Carter PH. Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672. ACS Med Chem Lett. 2019 Jan 16;10(3):300-305. doi: 10.1021/acsmedchemlett.8b00439. eCollection 2019 Mar 14. PMID: 30891130; PMCID: PMC6421546.
Copy
Download .nbib